Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder
Open accessThe DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Abstract
There is evidence for both similarity and distinction in the presentation and molecular characterization of schizophrenia and bipolar disorder. In this study, we characterized protein abnormalities in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder using two-dimensional gel electrophoresis. Tissue samples were obtained from 35 individuals with schizophrenia, 35 with bipolar disorder and 35 controls. Eleven protein spots in schizophrenia and 48 in bipolar disorder were found to be differentially expressed (P<0.01) in comparison to controls, with 7 additional spots found to be altered in both diseases. Using mass spectrometry, 15 schizophrenia-associated proteins and 51 bipolar disorder-associated proteins were identified. The functional groups most affected included synaptic proteins (7 of the 15) in schizophrenia and metabolic or mitochondrial-associated proteins (25 of the 51) in bipolar disorder. Six of seven synaptic-associated proteins abnormally expressed in bipolar disorder were isoforms of the septin family, while two septin protein spots were also significantly differentially expressed in schizophrenia. This finding represented the largest number of abnormalities from one protein family. All septin protein spots were upregulated in disease in comparison to controls. This study provides further characterization of the synaptic pathology present in schizophrenia and of the metabolic dysfunction observed in bipolar disorder. In addition, our study has provided strong evidence implicating the septin protein family of proteins in psychiatric disorders for the first time.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Proteomic analysis of SZ DLPFC samples identified 15 differentially expressed proteins, 7 of which were synaptic 164.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [164]
Citations
Cites
High resolution two-dimensional electrophoresis of proteins.
O'Farrell, P. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41496-8 · Cited by 19,246 · cited 1×
“5 ml Eppendorf tubes with 1 ml of solubilization buffer, a lysis buffer based on that originally used by O’Farrell”
MethodCorrelation between Protein and mRNA Abundance in Yeast
Gygi, S. P., Rochon, Y., Franza, B. R., & Aebersold, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1720 · Cited by 3,819
Subgenual prefrontal cortex abnormalities in mood disorders
Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
The dynamin superfamily: universal membrane tubulation and fission molecules?
Praefcke, G. J. K., & McMahon, H. T. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1313 · Cited by 1,377 · cited 1×
“0055) and is localized to presynaptic nerve terminals in the brain”
BackgroundPantelis, C., Velakoulis, D., McGorry, P. D., Wood, S. J., Suckling, J., Phillips, L. J., Yung, A. R., Bullmore, E. T., Brewer, W., Soulsby, B., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12323-9 · Cited by 1,310
A comparison of selected mRNA and protein abundances in human liver
Anderson, L., & Seilhamer, J. (1997) · ELECTROPHORESIS · doi:10.1002/elps.1150180333 · Cited by 1,262 · cited 1×
“27 However, mRNA may not be the most reliable method to use in order to gain insight into the underlying pathophysiology of schizophrenia, where abnormalities in gene function may or may not affect downstream protein expression”
MethodProteomic analysis of NMDA receptor–adhesion protein signaling complexes
Husi, H., Ward, M. A., Choudhary, J. S., Blackstock, W. P., & Grant, S. G. N. (2000) · Nature Neuroscience · doi:10.1038/76615 · Cited by 1,194
Hakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., Haroutunian, V., & Fienberg, A. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081071198 · Cited by 1,192
High rates of schizophrenia in adults with velo-cardio-facial syndrome
Murphy, K. C., Jones, L. A., & Owen, M. J. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.10.940 · Cited by 1,024 · cited 1×
“2, parts of which are deleted in velo–cardio–facial syndrome and whose sufferers have been found to have a much higher rate of schizophrenia than the general population (30p)”
Background
Research works printed but not linked: 4
- Eastwood SL, Burnet PW, Harrison PJ . Decreased hippocampal expression of the susceptibility gene PPP3CC and other calcineurin subunits in schizophrenia. Biol Psychiatry 2005; 57: 702–710. · DOI
- Sawada K, Barr AM, Nakamura M, Arima K, Young CE, Dwork AJ et al. Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. Arch Gen Psychiatry 2005; 62: 263–272. · DOI · Paper page
- Owen MJ, O’Donovan MC, Harrison PJ . Schizophrenia: a genetic disorder of the synapse? BMJ 2005; 330: 158–159. · DOI · Paper page
- Frankle WG, Lerma J, Laruelle M . The synaptic hypothesis of schizophrenia. Neuron 2003; 39: 205–216. · DOI · Paper page
Cited by
Items 101–200 of 227
Neurological Disorders in Schizophrenia
Danielyan, A., & Nasrallah, H. A. (2009) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.08.004 · Cited by 42
The use of Proteomic Biomarkers for Improved Diagnosis and Stratification Of Schizophrenia Patients
Guest, P. C., Chan, M. K., Gottschalk, M. G., & Bahn, S. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.13.83 · Cited by 35
The Adenosine Neuromodulation System in Schizophrenia
Rial, D., Lara, D. R., & Cunha, R. A. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00016-7 · Cited by 40
Kazuno, A., Ohtawa, K., Otsuki, K., Usui, M., Sugawara, H., Okazaki, Y., & Kato, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053855 · Cited by 32
“As indicated by an alteration in energy metabolism, compromised metabolic function has been reported in bipolar disorder [48,49].”
BackgroundZhou, K., Yang, Y., Gao, L., He, G., Li, W., Tang, K., Ji, B., Zhang, M., Yang, L., Yang, J., et al. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq132 · Cited by 33
“mic studies have revealed synaptic dysfunction of the dorsolateral prefrontal cortex in schizophrenia cases.(12) MK-801 ([þ]-5-methyl-10, 11-dihydro-5H-dibenzo-[a, d]-”
BackgroundProteomic approaches to unravel the complexity of schizophrenia
Martins‐de‐Souza, D., Guest, P. C., Rahmoune, H., & Bahn, S. (2012) · Expert Review of Proteomics · doi:10.1586/epr.11.70 · Cited by 34
Hayashi, A., Gal, K. L., Södersten, K., Vizlin‐Hodzic, D., Ågren, H., & Funa, K. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.104 · Cited by 34
Kartawy, M., Khaliulin, I., & Amal, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-70383-6 · Cited by 29
A CDC42EP4/septin-based perisynaptic glial scaffold facilitates glutamate clearance
Ageta‐Ishihara, N., Yamazaki, M., Konno, K., Nakayama, H., Abe, M., Hashimoto, K., Nishioka, T., Kaibuchi, K., Hattori, S., Miyakawa, T., et al. (2015) · Nature Communications · doi:10.1038/ncomms10090 · Cited by 33
Store-operated calcium entry in disease: Beyond STIM/Orai expression levels
Kappel, S., Borgström, A., Stokłosa, P., Dörr, K., & Peinelt, C. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.01.003 · Cited by 30
Nishimura, Y. V., Shinoda, T., Inaguma, Y., Ito, H., & Nagata, K. (2012) · Medical Molecular Morphology · doi:10.1007/s00795-011-0557-0 · Cited by 29
“It has been reported that the expression of SEPT5, SEPT6, and SEPT11 is upregulated in the prefrontal cortex of schizophrenic and bipolar patients.(45) Because pathogenesis of schizophrenia is well accepted to relate to cortical development, especially of the prefrontal area,(46) it is tempting to speculate that defec…”
BackgroundProteomic insights into synaptic signaling in the brain: the past, present and future
Xu, Y., Song, X., Wang, D., Wang, Y., Li, P., & Li, J. (2021) · Molecular Brain · doi:10.1186/s13041-021-00750-5 · Cited by 52
Kędracka–Krok, S., Świderska, B., Jankowska, U., Skupień-Rabian, B., Solich, J., Buczak, K., & Dziedzicka‐Wasylewska, M. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13007 · Cited by 31
“…et al. 2009) 53 CLO down Arp2/3 Actin-related protein 2/3 complex subunit 2 Up – post synaptic density (F€ocking et al. 2014) 79 CLO down PNP 14 Beta-synuclein Down – insular cortex (Pennington et al. 2008b) 83 CLO up Gal-5 Galectin-5 Down – white matter from the dorsolateral prefrontal…”
BackgroundInfluentialJones, A. L., Mowry, B. J., McLean, D. E., Mantzioris, B. X., Pender, M. P., & Greer, J. M. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.02.008 · Cited by 34
“Altered levels of the proteins identified as targets of antibodies by the 2D gel approach, namely NFM, GFAP and tubulin, have also previously been reported in the brains of schizophrenia patients (Sivagnanasundaram et al., 2007; Pennington et al., 2008; Martins-deSouza et al., 2009).”
Ginsberg, S. D., Hemby, S. E., & Smiley, J. F. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.09.015 · Cited by 30
“Downregulation of the GluR-interacting partners SAP102 and α-internexin have also been reported in BP (McCullumsmith et al., 2007; Pennington et al., 2008).”
BackgroundBenítez‐King, G., Valdés‐Tovar, M., Trueta, C., Galván‐Arrieta, T., Argueta, J., Alarcón-Elizalde, S., Lora-Castellanos, A., & Solís‐Chagoyán, H. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2016.01.013 · Cited by 33
Phosphoregulation of the septin cytoskeleton in neuronal development and disease
Werner, B., & Yadav, S. (2022) · Cytoskeleton · doi:10.1002/cm.21728 · Cited by 29
“…bipolar disorder, Down syndrome, hereditary neuralgic amyotrophy, and frontotemporal lobe degeneration (FTLD) (Chae et al., 2012; Cheon et al., 2001; Gozal et al., 2011; Ihara et al., 2003; Kinoshita et al., 1998; Kuhlenbäumer et al., 2005; Pennington et al., 2008; Peterson & Petty, 2010).”
BackgroundAndreazza, A. C., Barakauskas, V., Fazeli, S., Feresten, A. H., Shao, L., Wei, V., Wu, C. H., Barr, A. M., & Beasley, C. L. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.02.028 · Cited by 33
Self-citationSeptins, a cytoskeletal protein family, with emerging role in striated muscle
Gönczi, M., Dienes, B., Dobrosi, N., Fodor, J., Balogh, N., Oláh, T., & Csernoch, L. J. (2020) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-020-09573-8 · Cited by 30
Proteomic profiling in schizophrenia: enabling stratification for more effective treatment
Guest, P. C., Martins‐de‐Souza, D., Schwarz, E., Rahmoune, H., Alsaif, M., Tomasik, J., Turck, C. W., & Bahn, S. (2013) · Genome Medicine · doi:10.1186/gm429 · Cited by 29
“Proteomic studies of postmortem brain tissues in psychiatry have identified effects on proteins involved in cellular struc ture and transport [10], metabolism [11] and synaptic function [12,13], along with several proteins that are also found in serum or plasma, as described above [31].”
BackgroundMammalian septins in health and disease
Montagna, C., Weiler‐Sagie, M., & Zechmeister, J. R. (2015) · Research and Reports in Biochemistry · doi:10.2147/rrbc.s59060 · Cited by 31
“83 Deregulation of several proteins in the cerebral cortex of fetuses with Down syndrome included a decrease in the level of SEPT7, suggesting involvement in the developmental and cognitive impairment in this disease.”
Györffy, B. A., Gulyássy, P., Gellén, B., Völgyi, K., Madarasi, D., Kis, V., Ozohanics, O., Papp, I., Kovács, P., Lübec, G., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.04.002 · Cited by 31
Gene expression profiling of the dorsolateral and medial orbitofrontal cortex in schizophrenia
Mladinov, M., Sedmak, G., Fuller, H. R., Leko, M. B., Mayer, D., Kirincich, J., Štajduhar, A., Borovečki, F., Hof, P. R., & Šimić, G. (2016) · Translational Neuroscience · doi:10.1515/tnsci-2016-0021 · Cited by 27
“For the purpose of these comparisons, genes detected as repeated hits with separate identifiers (e.g., SEPT2 and GDI2; Table 3) were each counted separately because they most probably account for different splice variants.”
BackgroundResultInfluentialKim, H.-Y., Rhee, S. J., Lee, H., Han, D., Lee, T. Y., Kim, M., Kim, E. Y., Kwon, J. S., Shin, H., Kim, H., et al. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113850 · Cited by 32
Characterizing the proteome of the human dorsolateral prefrontal cortex by shotgun mass spectrometry
Martins‐de‐Souza, D., Guest, P. C., Steeb, H., Pietsch, S., Rahmoune, H., Harris, L. W., & Bahn, S. (2010) · PROTEOMICS · doi:10.1002/pmic.201000718 · Cited by 24
“The ten proteins identified by the greatest number of peptides were the structural proteins spectrin a-chain brain (SPTAN1, 143 peptides); spectrin b-chain brain 1 (SPTBN1, 131 peptides); clathrin heavy chain 1 (CLTC, 80 peptides); tubulin a 1B chain (TUBA1B, 73 peptides); tubulin a 1C chain (TUBA1C, 73 peptides); Ank…”
BackgroundRey, R., Suaud‐Chagny, M., Dorey, J., Teyssier, J., & d’Amato, T. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01052-5 · Cited by 26
zhang, T., Tang, Y., Yang, X., Wang, X., Ding, S., Huang, K., Liu, Y., & Lang, B. (2020) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2020.102520 · Cited by 25
Role of Proteomics in Biomarker Discovery
Patel, S. (2014) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-800168-4.00003-2 · Cited by 28
A proteomic investigation of similarities between conventional and herbal antidepressant treatments
Pennington, K., Föcking, M., McManus, C., Pariante, C. M., Dunn, M., & Cotter, D. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108091075 · Cited by 26
Self-citationThe proteome and its dynamics: A missing piece for integrative multi-omics in schizophrenia
Borgmann‐Winter, K. E., Wang, K., Bandyopadhyay, S., Torshizi, A. D., Blair, I. A., & Hahn, C.-G. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.07.025 · Cited by 22
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript cohort region extracts Proteomic method # altered proteins altered proteins Protein groups/ pathways Focking et al., 2011 20 SCZ 2 20 BPD 2 20 CTRL 2 Mid-HC cornu ammonis regions 2 and 3 whole cell Laser dissected 2D-DIGE mass spectrometry…”
MethodInfluentialSyndapin I Loss-of-Function in Mice Leads to Schizophrenia-Like Symptoms
Koch, N., Koch, D. C., Krueger, S., Tröger, J., Sabanov, V., Ahmed, T., McMillan, L. E., Wolf, D., Montag, D., Kessels, M. M., et al. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa013 · Cited by 25
Proteomic profiling of the retinal dysplasia and degeneration chick retina.
Finnegan, S., Robson, J. L., Hocking, P. M., Ali, M., Inglehearn, C. F., Stitt, A. W., & Curry, W. J. (2010) · PubMed · Cited by 23
English, J. A., Harauma, A., Föcking, M., Wynne, K. J., Scaife, C., Cagney, G., Moriguchi, T., & Cotter, D. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00208 · Cited by 21
“…implicated here (SEPT11, RHOB, RALA, DNM1L, RTN4, MYO5A), have expression changes consistent with decreased neuritogenesis (Chen et al., 2000; Rao et al., 2002; Lalli and Hall, 2005; Li et al., 2009; McNair et al., 2010; Dickey and Strack, 2011), suggesting that neuritogenesis is reduced as…”
BackgroundSelf-citationKim, H., Eom, C., Kwon, J. S., Joo, J., Lee, S., Nah, S., Kim, I., Jang, I., Chung, Y., Kim, S. I., et al. (2012) · PROTEOMICS · doi:10.1002/pmic.201100184 · Cited by 23
“The dorsolateral prefrontal cortex in schizophrenia was also investigated by proteomic analysis [13].”
MethodZhang, X., Li, Q., Zhang, M., Lam, S., Sham, P. C., Bu, B., Chua, S. E., Wang, W., & McAlonan, G. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145638 · Cited by 25
“0067 D-3-phosphoglycerate dehydrogenase gi|986918 Up [76] 51 1.”
InfluentialProteomics strategies for bipolar disorder evaluation: From sample preparation to validation
de Jesus, J. R., Pessôa, G. D. S., Sussulini, A., Capelo, J. L., & Arruda, M. A. Z. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.04.034 · Cited by 20
Behavioral Neurobiology of Bipolar Disorder and its Treatment
Manji, H. K., & Zarate, C. A. (2010) · Current topics in behavioral neurosciences · doi:10.1007/978-3-642-15757-8 · Cited by 23
Reig‐Viader, R., Sindreu, C. B., & Bayés, À. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.09.011 · Cited by 21
Approaches for targeted proteomics and its potential applications in neuroscience
Sethi, S., Chourasia, D., & Parhar, I. S. (2015) · Journal of Biosciences · doi:10.1007/s12038-015-9537-1 · Cited by 22
“…diseases (Ditzen et al. 2006; Mu et al. 2007; Patel et al. 2007; Szego et al. 2010; Otte et al. 2011; Robinson et al. 2011; Kim et al. 2013; Badhwar et al. 2014) and in patient cohorts (Johnston-Wilson et al. 2000; Castegna et al. 2002; Pennington et al. 2008; Martins-De- Souza et al. 2010).”
Mllt11 Regulates Migration and Neurite Outgrowth of Cortical Projection Neurons during Development
Stanton‐Turcotte, D., Hsu, K., Moore, S. A., Yamada, M., Fawcett, J. P., & Iulianella, A. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0124-22.2022 · Cited by 20
Radler, M. R., Liu, X., Peng, M., Doyle, B., Toyo-Oka, K., & Spiliotis, E. T. (2023) · Current Biology · doi:10.1016/j.cub.2022.11.043 · Cited by 17
Föcking, M., Opstelten, R., Prickaerts, J., Steinbusch, H. W. M., Dunn, M. J., van den Hove, D., & Cotter, D. (2014) · Developmental Neuroscience · doi:10.1159/000365327 · Cited by 18
Self-citationElmers, J., Colzato, L. S., Akgün, K., Ziemssen, T., & Beste, C. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102037 · Cited by 16
Metabolic pathways in the periphery and brain: Contribution to mental disorders?
Nagalski, A., Koziński, K., & Wisniewska, M. B. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.09.012 · Cited by 16
Recent advances in applying mass spectrometry and systems biology to determine brain dynamics
Scifo, E., Calza, G., Fuhrmann, M., Soliymani, R., Baumann, M., & Lalowski, M. M. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1335200 · Cited by 14
“RNA chaperoning functional groups [137,138].”
Proteomic analysis of PSD-93 knockout mice following the induction of ischemic cerebral injury
Rong, R., Yang, H., Rong, L., Wei, X., Li, Q., Liu, X., Gao, H., Xu, Y., & Zhang, Q. C. (2015) · NeuroToxicology · doi:10.1016/j.neuro.2015.12.005 · Cited by 13
Cassoli, J. S., Brandão‐Teles, C., Santana, A. G., Souza, G. H. M. F., & Martins‐de‐Souza, D. (2017) · PROTEOMICS · doi:10.1002/pmic.201700209 · Cited by 14
Ramos‐Miguel, A., Barakauskas, V., Alamri, J., Miyauchi, M., Barr, A. M., Beasley, C. L., Rosoklija, G. B., Mann, J. J., Dwork, A. J., Moradian, A., et al. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2018.12.045 · Cited by 13
“Mitochondrial proteins are identified as being dysregulated in proteomic studies of depression and schizophrenia (Pennington et al., 2008; Saia-Cereda and Martins-de-Souza, 2017).”
BackgroundSelf-citationDysregulation of Synaptic Plasticity Markers in Schizophrenia
Keshri, N., & Nandeesha, H. (2022) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-022-01068-2 · Cited by 11
Wesseling, H., Guest, P. C., Lago, S. G., & Bahn, S. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571400008x · Cited by 11
“…by guest on 28 July 2018 Prabakaran et al., 2004; Beasley et al., 2006; Clark et al., 2006; Novikova et al., 2006; Sivagnanasundaram et al., 2007; Pennington et al., 2008a, b; Behan et al., 2009; Martins-de-Souza et al., 2010, 2012; Chan et al., 2011; Focking et al., 2011; Wesseling et al.,…”
BackgroundEvidence of Glutamatergic Dysfunction in the Pathophysiology of Schizophrenia
Hammond, J. C., Shan, D., Meador‐Woodruff, J. H., & McCullumsmith, R. E. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1056-4_15 · Cited by 17
“There are reports of alterations in dynamin-1, amphiphysin, and AP-2, proteins involved in receptor endocytosis, in schizophrenia (Pennington et al. 2008; English et al. 2009; Focking et al. 2011).”
BackgroundKędracka–Krok, S., Świderska, B., Jankowska, U., Skupień-Rabian, B., Solich, J., & Dziedzicka‐Wasylewska, M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.12.028 · Cited by 10
“…been shown to influence neurite biogenesis in human neuroblastoma SH-SY5Y cells (Moreno-Baylach et al., 2011), and serinethreonine kinase receptor-associated protein (STRAP, up), which has been found to be up-regulated in the brains of schizophrenia patients (Pennington et al., 2008b) (Table 2).”
BackgroundDehghani, M., Kim, Q., Magistretti, P. J., & Xin, L. (2019) · Magnetic Resonance in Medicine · doi:10.1002/mrm.28066 · Cited by 15
“Normally-distributed random noise was added to the simulated spectra to create a range of different SNR (25-500).”
Kuang, L., Gao, W., Wang, L., Guo, Y., Cao, W., Cui, D., Jiao, Q., Qiu, J., Su, L., & Lu, G. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.08.025 · Cited by 11
Insights into myelin dysfunction in schizophrenia and bipolar disorder
Valdés‐Tovar, M., Rodríguez‐Ramírez, A. M., Rodríguez-Cárdenas, L., Sotelo-Ramírez, C. E., Camarena, B., Sanabrais‐Jiménez, M. A., Solís‐Chagoyán, H., Argueta, J., & López-Riquelme, G. O. (2022) · World Journal of Psychiatry · doi:10.5498/wjp.v12.i2.268 · Cited by 21
Unlocking the molecular mechanisms of antipsychotics – a new frontier for discovery
Bowling, H. L., & Santini, E. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14314 · Cited by 17
Septins in the nervous system: from cytoskeletal dynamics to neurological disorders
Alkhanjari, R. R., Alhajeri, M. M., Bhamidimarri, P. M., Alhosani, K. M., Kashir, J., Torii, T., & Hamdan, H. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02430-6 · Cited by 12
“Dysregulation of SEPT7 expression and function has been implicated in autism spectrum disorders [74], and altered expression in septine 5, 6, and 11 was observed in schizoprenia and bipolar disorders [118].”
The audacity of proteomics: a chance to overcome current challenges in schizophrenia research
Baloyianni, N. V., & Tsangaris, G. T. (2009) · Expert Review of Proteomics · doi:10.1586/epr.09.85 · Cited by 12
Coumans, J. V. F., Palanisamy, S., McFarlane, J. R., & Moens, P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040581 · Cited by 12
“[26] [27] [24] [28] [29] [30] [31] [32] [18] [33] [34] [35] [36] [37] [38] [39,40] [41] [42]”
Koopmans, F., Dijkstra, A. A., Li, W.-P., Klaassen, R. V., Gouwenberg, Y., Yao, S., Bast, L., Verhage, M., Karlsson, R., Dwork, A. J., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68950-y · Cited by 16
“We found high agreement (Pearson ’ s rho 0.89 and 0.79 for each Layer set, respectively) with Aryal et al. 17 with respect to the set of proteins (18 and 21 for each Layer set, respectively) identi fi ed at adjusted p -value< 0.1 in our study and their synaptosome preparations of the dorsolateral…”
InfluentialAbbs, B., Achalia, R. M., Adelufosi, A. O., Aktener, A. Y., Beveridge, N. J., Bhakta, S. G., Blackman, R. K., Bora, E., Byun, M. S., Cabanis, M., et al. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.07.024 · Cited by 11
Astrocyte Bioenergetics and Major Psychiatric Disorders
Maly, I. V., Morales, M. J., & Pletnikov, M. V. (2021) · Advances in neurobiology · doi:10.1007/978-3-030-77375-5_9 · Cited by 11
Föcking, M., Chen, W., Dicker, P., Dunn, M. J., Lübec, G., & Cotter, D. (2012) · PROTEOMICS · doi:10.1002/pmic.201200031 · Cited by 9
“Samples were processed and separated by 2D-Difference-in-Gel-Electrophoresis (2D-DIGE) as described previously by our group [13-17].”
MethodSelf-citationHerken, H., Başay, Ö., Başay, B. K., Alaçam, H., Öztürk, Ö., Büber, A., Yılmaz, Ş. G., Erdal, M. E., & Kıroğlu, Y. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s106076 · Cited by 9
“37 More specifically, Porton and Wetsel 38 reported reduced levels of synapsin III in schizophrenia patients.”
Roles of AMPA receptors in social behaviors
Xu, Q. W., Larosa, A., & Wong, T. P. (2024) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2024.1405510 · Cited by 7
Akil, A., Song, P., Peng, J., Gondeau, C., Samuel, D., & Gassama‐Diagne, A. (2021) · Pathogens · doi:10.3390/pathogens10101327 · Cited by 9
Vakalopoulos, C. (2010) · Mental Illness · doi:10.4081/mi.2010.e7 · Cited by 8
“increases in gene expression were observed for bipolar disorder.(87) Differential genomic”
BackgroundProteomics insight into psychiatric disorders: an update on biological fluid biomarkers
Giusti, L., Ciregia, F., Mazzoni, M. R., & Lucacchini, A. (2016) · Expert Review of Proteomics · doi:10.1080/14789450.2016.1230499 · Cited by 8
Proteomics is not only a biomarker discovery tool
Martins‐de‐Souza, D. (2009) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200900096 · Cited by 8
“BPD studies have shown in the dorsolateral prefrontal cortex and anterior cingulate cortex brain regions altered concentrations of a number of ATP subunits (which would compromise the oxidative phosphorylation process) and changes in antioxidant enzymes and proteins involved in ubiquination processes [10, 14], whilst…”
BackgroundAxonal transport deficits in neuropsychiatric disorders
Badal, K. K., & Puthanveettil, S. V. (2022) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2022.103786 · Cited by 8
Santarriaga, S., Gerlovin, K., Layadi, Y., & Karmacharya, R. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.02.029 · Cited by 7
Cell-Type-Specific Neuroproteomics of Synapses
Yim, Y. Y., & Nestler, E. J. (2023) · Biomolecules · doi:10.3390/biom13060998 · Cited by 7
Najdaghi, S., Davani, D. N., Fouladseresht, H., Ebrahimi, N., Sullman, M. J. M., Moradi, M., & Eskandari, N. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01518-w · Cited by 12
Neuroimaging and Neuropathological Findings in Bipolar Disorder
Savitz, J. B., & Drevets, W. C. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_68 · Cited by 9
Kandpal, M., Varshney, N., Rawal, K. S., & Jha, H. C. (2024) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2024.02.001 · Cited by 7
Farrelly, L. A., Rosato‐Siri, M. V., Föcking, M., Codagnone, M. G., Reinés, A. G., Dicker, P., Wynne, K. J., Farrell, M., Cannon, M. D., Cagney, G., et al. (2017) · PROTEOMICS · doi:10.1002/pmic.201600407 · Cited by 7
Self-citationRoosterman, D. (2014) · FEBS Journal · doi:10.1111/febs.13018 · Cited by 7
de Sousa, R. A. T. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2014.tde-05052014-142705 · Cited by 8
Vera-Montecinos, A., Rodríguez‐Mias, R. A., Vila, È., Villén, J., & Ramos, B. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1003557 · Cited by 6
“Several studies including genetic and proteomic studies have reported a disruption in the expression of synaptic vesicle proteins in this disorder (Pennington et al., 2008; Fromer et al., 2014; Egbujo et al., 2016; Onwordi et al., 2020).”
BackgroundMcManus, C. A., Polden, J., Cotter, D., & Dunn, M. J. (2010) · PROTEOMICS · doi:10.1002/pmic.200900705 · Cited by 5
“Grey matter dlPFC blocks contained seven control-pooled samples dissected from the frontal superior gyrus of Brodmann Area 9 [17].”
MethodResultInfluentialSelf-citationTargeted Proteomics for Validation of Biomarkers in Early Psychosis
English, J. A., Wynne, K. J., Cagney, G., & Cotter, D. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.11.016 · Cited by 5
Self-citationFolsom, T. D., Higgins, L., Markowski, T. W., Griffin, T. J., & Fatemi, S. H. (2018) · Synapse · doi:10.1002/syn.22069 · Cited by 6
A bioinformatic inquiry of the EAAT2 interactome in postmortem and neuropsychiatric datasets
Asah, S. M., Alganem, K., McCullumsmith, R. E., & O'Donovan, S. M. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.03.018 · Cited by 5
“This includes findings of altered metabolism at in the DLPFC (Pennington et al., 2008; Prabakaran et al., 2004) and ACC (Beasley et al., 2006; Clark et al., 2006, 2007; Martins-de-Souza et al., 2010b) but not the postsynaptic density (Focking et al., 2015) in schizophrenia.”
BackgroundБокша, И. С., Prokhorova, T. A., Savushkina, O. K., Терешкина, Е. Б., Vorobyeva, E. A., & Burbaeva, G. S. (2023) · Neurochemical Journal · doi:10.1134/s1819712423040086 · Cited by 5
Doostparast Torshizi, A., Duan, J., & Wang, K. (2020) · Patterns · doi:10.1016/j.patter.2020.100091 · Cited by 5
“For a full review on proteome studies in SCZ, refer to Borgmann-Winter et al. 14 In this study, we introduce MAPSD (Markov affinity-based proteogenomic signal diffusion), a multi-omics network-based computational method to identify novel risk genes for polygenic diseases.”
InfluentialFrankowska, A., Dudek, D., & Siwek, M. (2016) · Neuropsychiatria i Neuropsychologia · doi:10.5114/nan.2016.62250 · Cited by 2
Baharnoori, M., Bartholomeusz, C., Boucher, A. A., Buchy, L., Chaddock, C., Chiliza, B., Föcking, M., Fornito, A., Gallego, J. A., Hori, H., et al. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.09.008 · Cited by 8
Molecular Signatures of Schizophrenia and Insights into Potential Biological Convergence
Saada, M., & Stern, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199830 · Cited by 4
“Mass spectrometry studies of post-mortem cortical tissue have reported alterations in proteins associated with synaptic vesicle cycling, long-term potentiation machinery, and mitochondrial respiratory complexes [46,107].”
Self-Regulatory Neuronal Mechanisms and Long-Term Challenges in Schizophrenia Treatment
Markiewicz-Gospodarek, A., Markiewicz, R., Borowski, B., Dobrowolska, B. B., & Łoza, B. (2023) · Brain Sciences · doi:10.3390/brainsci13040651 · Cited by 4
Delgado-Sequera, A., Pérez‐Revuelta, J. I., García, A. C., Durán-Ruiz, M. C., Romero-López-Alberca, C., García-Mompó, C., González‐Sáiz, F., Rodríguez‐Iglesias, M., Morillo, D., Robledo, P., et al. (2024) · Molecular Medicine · doi:10.1186/s10020-024-01039-8 · Cited by 4
McDonald, A. J., & Mascagni, F. (2021) · The Journal of Comparative Neurology · doi:10.1002/cne.25169 · Cited by 3
“It is of interest, therefore, that alterations in NF subunit proteins in the brain have been seen in schizophrenia, bipolar disorder, depression, and drug addiction (FerrerAlc on et al., 2000, 2003; Pennington et al., 2008; Reines et al., 2004; Yuan & Nixon, 2016).”
BackgroundProteomics and Schizophrenia: The Evolution of a Great Partnership
Smith, B. J., Carregari, V. C., & Martins‐de‐Souza, D. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-97182-3_10 · Cited by 2
Normal Alert Consciousness: A Central Executive Model of Hippocampal Function
Burman, D. D. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.111569 · Cited by 3
Farrelly, L. A., Föcking, M., & Cotter, D. (2014) · Advances in biological psychiatry · doi:10.1159/000358028 · Cited by 2
Self-citationParticipation of Septin Cytoskeletal Proteins in the Nervous System Functioning
Bukharaeva, E. A., & Khuzakhmetova, V. F. (2018) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747818010026 · Cited by 3
“Overexpression of SEPT5, SEPT6, and SEPT11 was also identified in schizophrenia and bipolar disorder [59]; overexpression of SEPT9 was detected in a mouse model of demyelinating neuropathy [60].”
Proteomic Studies of Psychiatric Disorders
Guest, P. C. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7614-0_4 · Cited by 3
Donbaloğlu, E. N., Özcan, H., Donbaloğlu, M. A., Kızıltunç, A., & Eğilmez, E. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119921 · Cited by 1
Genetic and Proteomic Studies in Schizophrenia
Dias‐Neto, E., Martins‐de‐Souza, D., Ojopi, E. P. B., & Gattaz, W. F. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0913-8_10 · Cited by 1
Proteomics as a New Tool for Biomarker-Discovery in Neuropsychiatric Disorders
Raedler, T. J., Mischak, H., Jahn, H., & Wiedemann, K. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9464-4_6 · Cited by 1
Бокша, И. С., Prokhorova, T. A., Savushkina, O. K., Терешкина, Е. Б., Vorobyeva, E. A., & Burbaeva, G. S. (2023) · Нейрохимия · doi:10.31857/s1027813323040088 · Cited by 1
Metadata
- Authors
- Pennington, K., Beasley, C. L., Dicker, P., Fagan, A., English, J., Pariante, C. M., Wait, R., Dunn, M. J., & Cotter, D. R.
- Affiliations
- Royal College of Surgeons in Ireland (IE)
- University of British Columbia (CA)
- University College Dublin (IE)
- King's College London (GB)
- Imperial College London (GB)
- Corresponding author
- Cotter, D R
- Venue
- Molecular Psychiatry
- Published
- 2007-10-16
- Volume
- 13
- Issue
- 12
- Pages
- 1102-1117
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2084002557
- Cited by
- 227
- References
- 95
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 9 · 2022: 13 · 2021: 10 · 2020: 10 · 2019: 8 · 2018: 7 · 2017: 14 · 2016: 19 · 2015: 21 · 2014: 20 · 2013: 14 · 2012: 11
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Lincoln Repository (University of Lincoln) (acceptedVersion)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- schizophrenia, bipolar disorder, dorsolateral prefrontal cortex, synaptic proteins, mitochondrial proteins, metabolic dysfunction, differentially expressed proteins, mental illness
- MeSH terms
- Adult, Analysis of Variance, Bipolar Disorder, Chromatography, Liquid, Female, Humans, Male, Middle Aged, Schizophrenia, Electrophoresis, Gel, Two-Dimensional, Case-Control Studies, Databases, Factual, Prefrontal Cortex, Proteomics, Intracellular Signaling Peptides and Proteins, Tandem Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.